Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Warendorf

6 clinical trials in Warendorf, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Warendorf at a glance
6
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Warendorf

Open in trial search

Arteriosclerosis

Not recruiting

Study on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Arteriosclerosis+1

Not recruiting

A study testing DII235 compared to placebo in adults with high lipoprotein(a) levels to reduce heart disease risk

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Novartis Pharma AG

Arteriosclerosis

Not recruiting

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Rectal cancer

Not recruiting

Study Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Heidelberg University

Atrial fibrillation+2

Not recruiting

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Germany

The busiest research cities in the country

All 513 cities in Germany

Clinical research in Warendorf

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on lipoprotein reduction in patients with established cardiovascular disease, evaluating new therapeutic approaches to reduce major cardiovascular events.

  • Cardiovascular Disease Management
  • Lipid-Lowering Therapies
  • Preventive Cardiology

Advanced research exploring novel treatments to improve cardiovascular outcomes and patient care.

02 Stroke Prevention

Clinical investigations comparing new anticoagulation treatments for patients with atrial fibrillation, focusing on preventing stroke and systemic embolism while improving safety profiles.

  • Anticoagulation Therapy
  • Stroke Risk Management
  • Bleeding Risk Assessment

Comprehensive evaluation of innovative medications for better stroke prevention strategies.

03 Oncology Studies

Research evaluating treatment approaches for locally advanced rectal cancer, comparing pre-surgical and post-surgical chemotherapy protocols to optimize patient outcomes.

  • Colorectal Cancer Treatment
  • Surgical Timing Strategies
  • Disease-Free Survival

Groundbreaking studies aimed at improving survival rates and treatment effectiveness.

04 Respiratory Medicine

Investigation of new therapeutic options for Chronic Obstructive Pulmonary Disease, testing advanced medications as additions to standard triple therapy treatments.

  • COPD Management
  • Exacerbation Prevention
  • Respiratory Function

Focused research on improving quality of life for patients with chronic respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.